retatrutide peptide obesity triple hormone receptor agonist is changing the conversation around hunger and fat loss. Unlike medications that simply help you eat less, early research suggests Retatrutide may also activate glucagon pathways that support fat-burning—especially visceral fat Peptide Series #3 — Retatrutide

Neuron 21 , 907918 (1998) Patneau, D

Under these conditions, we measured a decrease in insulin secretion in response to exendin-4 versus vehicle conditions, primarily due to elevated basal secretion levels at 11 mM glucose (Figure 1E, F), confirming that increased cholesterol levels reduce the GLP-1R glucoregulatory potential by decreasing its capacity to potentiate islet insulin secretion

As the disease progresses, patients can develop more severe symptoms such as joint pain and heart problems (pubmed, ht et al)

I do see and feel it helping with my appetite

Li, X., Andersson, T., Ahlstrom, M

It fights almost any disease, particularly those associated with aging